Concepts (679)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatectomy | 128 | 2022 | 1800 | 18.690 |
Why?
|
| Prostatic Neoplasms | 227 | 2022 | 10525 | 16.290 |
Why?
|
| Cystectomy | 68 | 2022 | 628 | 14.970 |
Why?
|
| Nephrectomy | 80 | 2020 | 993 | 10.820 |
Why?
|
| Urinary Bladder Neoplasms | 71 | 2022 | 2029 | 10.690 |
Why?
|
| Androgen Antagonists | 31 | 2022 | 1269 | 5.950 |
Why?
|
| Robotics | 38 | 2018 | 859 | 5.700 |
Why?
|
| Kidney Neoplasms | 90 | 2022 | 3970 | 5.580 |
Why?
|
| Prostate-Specific Antigen | 51 | 2022 | 2245 | 5.100 |
Why?
|
| SEER Program | 72 | 2021 | 1549 | 4.560 |
Why?
|
| Carcinoma, Renal Cell | 64 | 2021 | 2910 | 4.220 |
Why?
|
| Postoperative Complications | 81 | 2022 | 15053 | 4.050 |
Why?
|
| Laparoscopy | 35 | 2019 | 1981 | 3.950 |
Why?
|
| Carcinoma, Transitional Cell | 26 | 2021 | 768 | 3.830 |
Why?
|
| Healthcare Disparities | 35 | 2021 | 2996 | 3.820 |
Why?
|
| Early Detection of Cancer | 31 | 2022 | 2865 | 3.780 |
Why?
|
| Prostate | 25 | 2022 | 1564 | 3.350 |
Why?
|
| Urologic Neoplasms | 9 | 2022 | 316 | 3.280 |
Why?
|
| Urologic Surgical Procedures | 14 | 2017 | 293 | 3.180 |
Why?
|
| Urology | 15 | 2021 | 368 | 3.090 |
Why?
|
| Male | 490 | 2022 | 349524 | 2.950 |
Why?
|
| Hospitals | 25 | 2022 | 3290 | 2.950 |
Why?
|
| Lymph Node Excision | 25 | 2021 | 1179 | 2.940 |
Why?
|
| Prostatic Hyperplasia | 10 | 2022 | 511 | 2.930 |
Why?
|
| Aged | 339 | 2022 | 161488 | 2.740 |
Why?
|
| Transurethral Resection of Prostate | 6 | 2022 | 76 | 2.700 |
Why?
|
| United States | 194 | 2022 | 67165 | 2.640 |
Why?
|
| Urogenital Neoplasms | 6 | 2021 | 140 | 2.380 |
Why?
|
| Humans | 566 | 2022 | 708843 | 2.370 |
Why?
|
| African Americans | 27 | 2021 | 5118 | 2.300 |
Why?
|
| Neoplasms | 34 | 2022 | 20172 | 2.300 |
Why?
|
| Watchful Waiting | 14 | 2019 | 451 | 2.270 |
Why?
|
| Antineoplastic Agents, Hormonal | 13 | 2022 | 1521 | 2.250 |
Why?
|
| Middle Aged | 312 | 2022 | 213752 | 2.230 |
Why?
|
| Urolithiasis | 6 | 2019 | 116 | 2.200 |
Why?
|
| Colectomy | 6 | 2021 | 651 | 2.150 |
Why?
|
| Databases, Factual | 52 | 2022 | 7763 | 2.080 |
Why?
|
| Surgical Procedures, Operative | 7 | 2021 | 1880 | 2.040 |
Why?
|
| Neoplasm Staging | 74 | 2021 | 11126 | 2.010 |
Why?
|
| Erectile Dysfunction | 6 | 2019 | 447 | 1.940 |
Why?
|
| Patient Readmission | 17 | 2021 | 2952 | 1.940 |
Why?
|
| Brachytherapy | 12 | 2019 | 1298 | 1.920 |
Why?
|
| Orchiectomy | 7 | 2016 | 456 | 1.910 |
Why?
|
| Kallikreins | 12 | 2020 | 267 | 1.900 |
Why?
|
| Finasteride | 4 | 2022 | 88 | 1.840 |
Why?
|
| Patient Protection and Affordable Care Act | 13 | 2021 | 1161 | 1.830 |
Why?
|
| Medicare | 21 | 2022 | 5691 | 1.800 |
Why?
|
| Blood Transfusion | 26 | 2020 | 1246 | 1.800 |
Why?
|
| Medically Uninsured | 10 | 2020 | 862 | 1.760 |
Why?
|
| Nephrostomy, Percutaneous | 6 | 2017 | 82 | 1.750 |
Why?
|
| Length of Stay | 49 | 2021 | 6257 | 1.750 |
Why?
|
| Aged, 80 and over | 126 | 2022 | 58184 | 1.690 |
Why?
|
| Insurance, Health | 13 | 2020 | 2475 | 1.680 |
Why?
|
| Health Services Accessibility | 17 | 2021 | 4988 | 1.640 |
Why?
|
| Retrospective Studies | 139 | 2022 | 71483 | 1.610 |
Why?
|
| Suicide | 5 | 2021 | 1558 | 1.590 |
Why?
|
| Risk Assessment | 61 | 2021 | 23284 | 1.550 |
Why?
|
| Urologic Diseases | 3 | 2017 | 252 | 1.510 |
Why?
|
| Gonadotropin-Releasing Hormone | 6 | 2020 | 1188 | 1.480 |
Why?
|
| Hysterectomy | 5 | 2020 | 902 | 1.480 |
Why?
|
| Testicular Neoplasms | 7 | 2020 | 751 | 1.470 |
Why?
|
| Perioperative Period | 11 | 2021 | 262 | 1.450 |
Why?
|
| Neoadjuvant Therapy | 11 | 2019 | 2561 | 1.440 |
Why?
|
| Laser Therapy | 6 | 2022 | 1059 | 1.440 |
Why?
|
| Inpatients | 13 | 2021 | 2207 | 1.410 |
Why?
|
| Medicaid | 11 | 2021 | 2613 | 1.390 |
Why?
|
| Patient Admission | 6 | 2017 | 1398 | 1.350 |
Why?
|
| Insurance Coverage | 13 | 2021 | 1847 | 1.340 |
Why?
|
| Treatment Outcome | 113 | 2022 | 61932 | 1.340 |
Why?
|
| Hospitalization | 21 | 2021 | 9644 | 1.330 |
Why?
|
| Female | 237 | 2022 | 375205 | 1.310 |
Why?
|
| Ureteral Neoplasms | 10 | 2021 | 87 | 1.290 |
Why?
|
| Kidney Pelvis | 7 | 2019 | 182 | 1.290 |
Why?
|
| Asian Americans | 4 | 2017 | 699 | 1.240 |
Why?
|
| Hospital Mortality | 30 | 2019 | 5095 | 1.180 |
Why?
|
| Quality Improvement | 13 | 2022 | 3733 | 1.170 |
Why?
|
| Nomograms | 10 | 2017 | 225 | 1.170 |
Why?
|
| Hormone Replacement Therapy | 5 | 2022 | 732 | 1.170 |
Why?
|
| Health Care Costs | 11 | 2022 | 3152 | 1.160 |
Why?
|
| Survival Rate | 47 | 2021 | 13202 | 1.140 |
Why?
|
| Urinary Tract Infections | 6 | 2015 | 781 | 1.130 |
Why?
|
| Logistic Models | 50 | 2022 | 13468 | 1.110 |
Why?
|
| Health Expenditures | 5 | 2020 | 2240 | 1.110 |
Why?
|
| Hospital Charges | 6 | 2017 | 362 | 1.080 |
Why?
|
| Ureteral Obstruction | 4 | 2015 | 301 | 1.080 |
Why?
|
| Urothelium | 8 | 2021 | 285 | 1.080 |
Why?
|
| Survival Analysis | 40 | 2022 | 10507 | 1.080 |
Why?
|
| Incidence | 48 | 2021 | 20320 | 1.070 |
Why?
|
| Behavioral Risk Factor Surveillance System | 9 | 2021 | 182 | 1.060 |
Why?
|
| Quality of Health Care | 8 | 2020 | 4266 | 1.040 |
Why?
|
| Multivariate Analysis | 47 | 2021 | 12447 | 1.040 |
Why?
|
| Life Expectancy | 6 | 2019 | 1116 | 1.040 |
Why?
|
| Uterine Cervical Neoplasms | 5 | 2020 | 1962 | 1.030 |
Why?
|
| Quality Indicators, Health Care | 6 | 2019 | 1822 | 1.030 |
Why?
|
| Venous Thromboembolism | 8 | 2020 | 1537 | 1.020 |
Why?
|
| Urinary Incontinence | 5 | 2014 | 457 | 1.000 |
Why?
|
| 5-alpha Reductase Inhibitors | 3 | 2022 | 104 | 0.990 |
Why?
|
| Adult | 128 | 2022 | 211041 | 0.980 |
Why?
|
| Muscle Neoplasms | 3 | 2019 | 146 | 0.960 |
Why?
|
| Decompression | 2 | 2012 | 45 | 0.960 |
Why?
|
| Propensity Score | 19 | 2020 | 1715 | 0.960 |
Why?
|
| Ureter | 10 | 2015 | 360 | 0.950 |
Why?
|
| Cost of Illness | 8 | 2017 | 1820 | 0.950 |
Why?
|
| Urinary Bladder | 11 | 2020 | 1125 | 0.950 |
Why?
|
| Urethral Obstruction | 1 | 2022 | 51 | 0.930 |
Why?
|
| Neoplasm Invasiveness | 19 | 2020 | 3693 | 0.920 |
Why?
|
| Proportional Hazards Models | 40 | 2021 | 12292 | 0.910 |
Why?
|
| Comparative Effectiveness Research | 7 | 2018 | 672 | 0.910 |
Why?
|
| Urinary Catheterization | 3 | 2012 | 194 | 0.900 |
Why?
|
| Referral and Consultation | 5 | 2021 | 3436 | 0.890 |
Why?
|
| Risk Factors | 84 | 2021 | 69553 | 0.890 |
Why?
|
| Breast Neoplasms | 13 | 2020 | 19800 | 0.880 |
Why?
|
| Registries | 11 | 2019 | 7989 | 0.870 |
Why?
|
| Prognosis | 59 | 2022 | 28919 | 0.870 |
Why?
|
| Current Procedural Terminology | 1 | 2022 | 88 | 0.860 |
Why?
|
| Absenteeism | 2 | 2020 | 274 | 0.860 |
Why?
|
| Nephritis | 1 | 2022 | 160 | 0.860 |
Why?
|
| Colorectal Neoplasms | 11 | 2020 | 6497 | 0.850 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 4 | 2020 | 475 | 0.840 |
Why?
|
| Intraoperative Complications | 12 | 2014 | 1192 | 0.840 |
Why?
|
| Androgens | 5 | 2022 | 1216 | 0.830 |
Why?
|
| Antineoplastic Protocols | 1 | 2020 | 51 | 0.830 |
Why?
|
| Lymphatic Metastasis | 30 | 2021 | 2951 | 0.810 |
Why?
|
| Time Factors | 56 | 2020 | 41038 | 0.810 |
Why?
|
| Statistics as Topic | 2 | 2017 | 2402 | 0.810 |
Why?
|
| Convalescence | 1 | 2020 | 107 | 0.800 |
Why?
|
| BCG Vaccine | 3 | 2022 | 354 | 0.800 |
Why?
|
| Chemotherapy, Adjuvant | 19 | 2019 | 3515 | 0.800 |
Why?
|
| Muscles | 4 | 2022 | 1622 | 0.790 |
Why?
|
| Odds Ratio | 26 | 2019 | 9754 | 0.790 |
Why?
|
| Mass Screening | 11 | 2021 | 5182 | 0.770 |
Why?
|
| Hormone Antagonists | 1 | 2020 | 110 | 0.770 |
Why?
|
| Testosterone | 4 | 2019 | 2352 | 0.770 |
Why?
|
| Kaplan-Meier Estimate | 26 | 2021 | 6765 | 0.770 |
Why?
|
| Penile Implantation | 1 | 2019 | 14 | 0.770 |
Why?
|
| Bone Neoplasms | 5 | 2016 | 2579 | 0.750 |
Why?
|
| Ambulatory Surgical Procedures | 4 | 2021 | 450 | 0.730 |
Why?
|
| Minority Health | 2 | 2019 | 85 | 0.720 |
Why?
|
| Quality of Life | 12 | 2022 | 11594 | 0.720 |
Why?
|
| Health Literacy | 2 | 2020 | 388 | 0.720 |
Why?
|
| Health Surveys | 3 | 2018 | 3994 | 0.710 |
Why?
|
| Marital Status | 5 | 2016 | 437 | 0.710 |
Why?
|
| Pelvic Neoplasms | 1 | 2020 | 246 | 0.710 |
Why?
|
| Age Factors | 30 | 2021 | 18712 | 0.700 |
Why?
|
| Kidney Calculi | 5 | 2017 | 441 | 0.690 |
Why?
|
| Hospice Care | 2 | 2015 | 609 | 0.690 |
Why?
|
| Patient Selection | 9 | 2020 | 4306 | 0.680 |
Why?
|
| Spinal Fusion | 2 | 2019 | 1175 | 0.670 |
Why?
|
| Follow-Up Studies | 42 | 2021 | 39038 | 0.660 |
Why?
|
| Comorbidity | 16 | 2021 | 10339 | 0.650 |
Why?
|
| Military Personnel | 3 | 2021 | 1050 | 0.650 |
Why?
|
| Patient Acceptance of Health Care | 3 | 2020 | 2927 | 0.640 |
Why?
|
| Young Adult | 38 | 2021 | 55940 | 0.630 |
Why?
|
| Choice Behavior | 2 | 2021 | 793 | 0.630 |
Why?
|
| Anxiety | 4 | 2021 | 3887 | 0.630 |
Why?
|
| Surgery, Computer-Assisted | 4 | 2013 | 1018 | 0.630 |
Why?
|
| Preventive Health Services | 3 | 2018 | 583 | 0.630 |
Why?
|
| Empathy | 1 | 2021 | 442 | 0.620 |
Why?
|
| Hospital Costs | 7 | 2017 | 982 | 0.620 |
Why?
|
| Socioeconomic Factors | 18 | 2021 | 7644 | 0.620 |
Why?
|
| Dementia | 2 | 2019 | 2227 | 0.610 |
Why?
|
| Hypoalbuminemia | 1 | 2016 | 60 | 0.610 |
Why?
|
| Neoplasm Recurrence, Local | 26 | 2019 | 8877 | 0.600 |
Why?
|
| Analgesics, Opioid | 3 | 2020 | 3308 | 0.590 |
Why?
|
| Surgical Wound Infection | 4 | 2015 | 1490 | 0.590 |
Why?
|
| Myocarditis | 1 | 2022 | 684 | 0.580 |
Why?
|
| Minority Groups | 4 | 2020 | 1077 | 0.570 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2021 | 568 | 0.560 |
Why?
|
| Data Interpretation, Statistical | 3 | 2022 | 2716 | 0.560 |
Why?
|
| Adjuvants, Immunologic | 2 | 2020 | 954 | 0.560 |
Why?
|
| Cohort Studies | 40 | 2022 | 39292 | 0.560 |
Why?
|
| Emergency Service, Hospital | 9 | 2017 | 7428 | 0.560 |
Why?
|
| Surgical Wound Dehiscence | 2 | 2017 | 215 | 0.550 |
Why?
|
| Patient Discharge | 4 | 2019 | 2980 | 0.550 |
Why?
|
| Lung Neoplasms | 8 | 2021 | 12183 | 0.540 |
Why?
|
| Neoplasms, Hormone-Dependent | 2 | 2014 | 414 | 0.530 |
Why?
|
| Sepsis | 4 | 2016 | 2449 | 0.530 |
Why?
|
| Accidents | 1 | 2015 | 167 | 0.530 |
Why?
|
| Adenocarcinoma | 7 | 2019 | 6338 | 0.530 |
Why?
|
| Orthopedic Procedures | 2 | 2015 | 1278 | 0.520 |
Why?
|
| Combined Modality Therapy | 16 | 2021 | 8896 | 0.520 |
Why?
|
| Insurance Benefits | 1 | 2016 | 179 | 0.510 |
Why?
|
| Urinary Incontinence, Stress | 1 | 2015 | 171 | 0.510 |
Why?
|
| Adrenalectomy | 1 | 2015 | 307 | 0.510 |
Why?
|
| Lymph Nodes | 11 | 2020 | 3409 | 0.510 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2015 | 211 | 0.500 |
Why?
|
| Workplace | 1 | 2020 | 852 | 0.490 |
Why?
|
| Priapism | 1 | 2013 | 28 | 0.490 |
Why?
|
| Fees, Medical | 1 | 2014 | 115 | 0.490 |
Why?
|
| Surgical Mesh | 1 | 2015 | 250 | 0.490 |
Why?
|
| Ureteral Calculi | 2 | 2017 | 103 | 0.490 |
Why?
|
| Intestinal Obstruction | 1 | 2016 | 415 | 0.480 |
Why?
|
| Hospitals, Teaching | 3 | 2017 | 1156 | 0.470 |
Why?
|
| Muscle, Smooth | 1 | 2017 | 945 | 0.470 |
Why?
|
| Patient Preference | 2 | 2019 | 856 | 0.470 |
Why?
|
| Regression Analysis | 17 | 2021 | 6451 | 0.470 |
Why?
|
| Adolescent | 42 | 2021 | 84718 | 0.470 |
Why?
|
| Biopsy | 9 | 2019 | 6766 | 0.470 |
Why?
|
| Artificial Intelligence | 2 | 2022 | 1661 | 0.470 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2014 | 318 | 0.470 |
Why?
|
| Pelvis | 10 | 2020 | 685 | 0.460 |
Why?
|
| Periodicity | 1 | 2014 | 377 | 0.460 |
Why?
|
| Pancreatectomy | 2 | 2015 | 845 | 0.460 |
Why?
|
| Cancer Care Facilities | 5 | 2018 | 414 | 0.460 |
Why?
|
| Melanoma | 2 | 2021 | 5194 | 0.460 |
Why?
|
| Seminal Vesicles | 4 | 2021 | 107 | 0.450 |
Why?
|
| Cost Savings | 5 | 2021 | 925 | 0.450 |
Why?
|
| Community-Acquired Infections | 1 | 2016 | 466 | 0.450 |
Why?
|
| Fee-for-Service Plans | 1 | 2017 | 650 | 0.450 |
Why?
|
| Learning Curve | 1 | 2013 | 202 | 0.450 |
Why?
|
| Biopsy, Needle | 3 | 2018 | 1682 | 0.440 |
Why?
|
| Renal Insufficiency, Chronic | 3 | 2014 | 1938 | 0.440 |
Why?
|
| Economics, Hospital | 1 | 2014 | 198 | 0.440 |
Why?
|
| Health Status Disparities | 4 | 2018 | 1711 | 0.430 |
Why?
|
| Thromboembolism | 1 | 2018 | 985 | 0.430 |
Why?
|
| Lung Diseases | 2 | 2021 | 1889 | 0.420 |
Why?
|
| Veterans | 2 | 2021 | 2288 | 0.420 |
Why?
|
| Colonic Neoplasms | 2 | 2020 | 2535 | 0.410 |
Why?
|
| Observation | 1 | 2013 | 310 | 0.410 |
Why?
|
| Practice Guidelines as Topic | 10 | 2019 | 7487 | 0.410 |
Why?
|
| Medical Oncology | 4 | 2022 | 2098 | 0.400 |
Why?
|
| Angina Pectoris | 1 | 2015 | 1010 | 0.400 |
Why?
|
| Vagina | 1 | 2015 | 777 | 0.400 |
Why?
|
| Access to Information | 1 | 2014 | 304 | 0.400 |
Why?
|
| Postoperative Hemorrhage | 1 | 2014 | 416 | 0.400 |
Why?
|
| Postoperative Period | 5 | 2021 | 1843 | 0.400 |
Why?
|
| Device Removal | 1 | 2015 | 656 | 0.390 |
Why?
|
| Health Status Indicators | 3 | 2014 | 987 | 0.390 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 7 | 2019 | 11253 | 0.390 |
Why?
|
| Intestine, Small | 1 | 2016 | 1235 | 0.390 |
Why?
|
| Income | 4 | 2014 | 1775 | 0.390 |
Why?
|
| Neoplasm Metastasis | 13 | 2020 | 5112 | 0.390 | |